JW Shinyak Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Shinyak Corp with three other
companies in this sector in South Korea:
Dongsung Pharmaceutical Company Limited
sales of 74.66 billion Korean Won [US$65.78 million]
of which 86%
was Pharmaceutical Segment),
Nutri Biotech Co Ltd
(77.52 billion Korean Won [US$68.29 million]
Celltrion Pharm Incorporated
(74.73 billion Korean Won [US$65.84 million]
of which 100%
JW Shinyak Corp reported sales of 76.95 billion Korean Won (US$67.79 million)
December of 2015.
increase of 5.4%
versus 2014, when the company's sales were 73.02 billion Korean Won.
This was the third consecutive year of growth at JW Shinyak Corp.